While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. Keeping that in mind, here is one cash-producing company that excels at turning cash into shareholder value and two best left off your watchlist.
Two Stocks to Sell:
PlayStudios (MYPS)
Trailing 12-Month Free Cash Flow Margin: 10.8%
Founded by a team of former gaming industry executives, PlayStudios (NASDAQ: MYPS) offers free-to-play digital casino games.
Why Is MYPS Risky?
- Annual sales declines of 2.7% for the past five years show its products and services struggled to connect with the market
- Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 12.8% for the last two years
At $0.45 per share, PlayStudios trades at 0.2x forward price-to-sales. If you’re considering MYPS for your portfolio, see our FREE research report to learn more.
Gates Industrial Corporation (GTES)
Trailing 12-Month Free Cash Flow Margin: 10.6%
Helping create one of the most memorable moments for the iconic “Jurassic Park” film, Gates (NYSE: GTES) offers power transmission and fluid transfer equipment for various industries.
Why Is GTES Not Exciting?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Estimated sales growth of 3.8% for the next 12 months is soft and implies weaker demand
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
Gates Industrial Corporation is trading at $22.09 per share, or 14.1x forward P/E. Check out our free in-depth research report to learn more about why GTES doesn’t pass our bar.
One Stock to Watch:
Cigna (CI)
Trailing 12-Month Free Cash Flow Margin: 2.7%
With roots dating back to 1792 and serving millions of customers across the globe, The Cigna Group (NYSE: CI) provides healthcare services through its Evernorth Health Services and Cigna Healthcare segments, offering pharmacy benefits, specialty care, and medical plans.
Why Do We Like CI?
- Annual revenue growth of 18.6% over the last two years was superb and indicates its market share increased during this cycle
- Massive revenue base of $274.7 billion gives it meaningful leverage when negotiating reimbursement rates
- Earnings growth has easily exceeded the peer group average over the last five years as its EPS has compounded at 10.1% annually
Cigna’s stock price of $261.73 implies a valuation ratio of 9x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
